Oxidants/antioxidants and COPD

Chest

Volumn 117, Issue 5 SUPPL. 1, 2000, Pages 303S-317S

  MacNee, William ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Antioxidant; COPD; Oxidants; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; ANTIOXIDANT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; OXIDIZING AGENT; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG SEQUESTRATION; OXIDATIVE STRESS; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL;

EID: 0034034334     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.5_suppl_1.303S-a     Document Type: Conference Paper

References (144)

1. British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(Suppl 5):S1-S28
2. Church T, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64:111-126
3. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 1996; 21:669-681
4. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals hydrogen peroxides peroxynitrate and peroxynitrite. Annals N Y Acad Sci 1993; 686:12-28
5. Zang KY, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 1995; 19:161-167
6. Nakayama T, Church DF, Pryor WA. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med 1989; 7:9-15
7. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann NY Acad Sci USA 1993; 686:289-298
8. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128:833-838
9. Morrison D, Rahman I, Lannan S, et al. Epithelial permeability inflammation and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999; 159:473-479
10. Mateos F, Brock JF, Perez-Arellano JL. Iron metabolism in the lower respiratory tract. Thorax 1998; 53:594-600
11. Thompson AB, Bohling T, Heires A, et al. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med 1991; 117:494-499
12. Wesselius LJ, Nelson ME, Skikne BS. Increased release of ferritin and iron by iron loaded alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med 1994; 150: 690-695
13. Cantin A, Crystal RG. Oxidants, antioxidants and the pathogenesis of emphysema. Eur J Respir Dis 1985; 66(Suppl 139):7-17
14. Laurent P, Janoff A, Kagan HM. Cigarette smoke blocks cross-linking of elastin in vitro. Am Rev Respir Dis 1983; 127:189-192
15. Cross CE, Van der Vliet A, O'Neill CA, et al. Oxidants antioxidants and respiratory tract lining fluids. Environ Health Perspect 1994; 102(Suppl 10):185-191
16. Cross CE, Halliwell B, Allen A. Antioxidant protection: a function of tracheobronchial and gastrointestinal mucus. Lancet 1984; 1:1328-1330
17. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells on the respiratory tract. Thorax 1994; 49:825-834
18. Jones JG, Lawler P, Crawley JCW, et al. Increased alveolar epithelial permeability in cigarette smokers. Lancet 19801: 66-68
19. Lannan S, Donaldson K, Brown D, et al. Effects of cigarette smoke and its condensates on alveolar cell injury in vitro. Am J Physiol 1994; 266:L92-L100
20. Li XY, Donaldson K, Rahman I, et al. An investigation of the role of glutathione in the increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med 1994; 149:1518-1525
21. Li XY, Rahman I, Donaldson K, et al. Mechanisms of cigarette smoke induced increased airspace permeability. Thorax 1996; 51:465-471
22. Rahman I, Li XY, Donaldson K, et al. Cigarette smoke glutathione metabolism and epithelial permeability in rat lungs. Biochem Soc Trans 1995; 23:2355
23. Li XY, Donaldson K, Brown D, et al. The role of tumour necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am J Respir Cell Mol Biol 1995; 13:185-195
24. Morrison D, Rahman I, Lannan S, et al. Epithelial permeability, inflammation and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999; 159:473-479
25. Kilburn K, McKenzie W. Leukocyte recruitment to airways by cigarette smoke and particle phase in contrast to cytotoxicity of vapor. Science 1975; 189:634-637
26. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128:833-838
27. Schaberg T, Haller H, Rau M, et al. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur Respir J 1992; 5:387-393
28. Richards GA, Therson AJ, Carel A, et al. Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am Rev Respir Dis 1989; 139:181-187
29. Davis WB, Pacht ER, Spatafora M, et al. Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers. J Lab Clin Med 1988; 111:293-298
30. Ludwig PW, Hoidal JR. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis 1982; 126:977-980
31. Hoidal JR, Fox RB, LeMarbe PA, et al. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis 1981; 123:85-89
32. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53:129-136
33. Pinamonti S, Muzzuli M, Chicca C, et al. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive lung disease. Free Radic Biol Med 1996; 21:147-155
34. MacNee W, Selby C. Neutrophil traffic in the lungs, the role of hemodynamics, cell adhesion and deformability. Thoxax 1993; 48:79-88
35. Selby C, Drost E, Wraith PK, et al. In vivo neutrophil sequestration within the lungs of man is determined by in vitro 'filterability'. J Appl Physiol 1991; 71:1996-2003
36. Hogg JC. Neutrophil kinetics and lung injury. Physiol Rev 1987; 67:1249-1295
37. MacNee W, Wiggs B, Belzberg AS, et al. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989; 321:924-928
38. Drost EM, Selby C, Lannan S, et al. Changes in neutrophil deformability following in vitro smoke exposure: mechanism and protection. Am J Respir Cell Mol Biol 1992; 6:287-295
39. Drost E, Selby C, Bridgeman MME, et al. Decreased leukocyte deformability following acute cigarette smoking in smokers. Am Rev Respir Dis 1993; 148:1277-1283
40. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154:1055-1060
41. Lehr HA, Kress E, Menger MD, et al. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: inhibition by CuZnSOD. Free Radic Biol Med 1993; 14:573-581
42. Klut ME, Doerschuk CM, Hogg JC, et al. Activation of neutrophils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am J Respir Cell Mol Biol 1993; 9:82-90
43. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989; 109:1341-1349
44. Selby C, Drost E, Brown D, et al. Inhibition of neutrophil adherence and movement by acute cigarette smoke exposure. Exp Lung Res 1992; 18:813-827
45. Selby C, Drost E, Lannan S, et al. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1991; 143:1359-1364
46. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant/ antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 1997; 52:565-568
47. Bosken CH, Doerschuk CM, English D, et al. Neutrophil kinetics during active cigarette smoking in rabbits. J Appl Physiol 1991; 71:830-837
48. Brown DM, Drost E, Donaldson K, et al. Deformability and CD11/CD18 expression of sequestered neutrophils in normal and inflamed lungs. Am J Respir Cell Mol Biol 1995; 13:531-539
49. Morrison D, Stricter RM, Donnelly SC, et al. Neutrophil chemokines in BALF and leukocyte conditioned medium from non-smokers and smokers. Eur Respir J 1998; 12:1067-72
50. MacNee W. Chronic obstructive pulmonary disease from science to the clinic: the role of glutathione in oxidant-antioxidant balance. Monaldi Arch Chest Dis 1997; 52:479-485
51. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and in chronic obstructive pulmonary disease. Thorax 1996; 51:348-350
52. Repine JE, Bast A, Lankhorst I, et al. Oxidant stress and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:341-357
53. Stockley RA. Antielastases in lung lavage from patients with emphysema. In: Taylor JC, Mittman C, eds. Pulmonary emphysema and proteolysis. Orlando, FL: Academic Press, 1986; 277-282
54. Hubbard RC, Ogushi F, Fels GA, et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80:1289-1295
55. Kramps JA, Rudolphus A, Stolk J, et al. Role of antileukoprotease in the lung. Ann N Y Acad Sci USA 1991; 624:97-108
56. Kramps JA, van Twisk C, Dijkman DH. Oxidative inactivation of antileukoprotease is triggered by polymorphonuclear leukocytes. Clin Sci 1988; 75:53-62
57. Johnson D, Travis J. The oxidative inactivation of human ∝1-proteinase inhibitor: further evidence for methionine at the reactive center. J Biol Chem 1979; 254:4022-4026
58. Carp H, Janoff A. Possible mechanisms of emphysema in smokers: in vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by anti-oxidants. Am Rev Respir Dis 1978; 118:617-621
59. Gadek J, Fells GA, Crystal RG. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science 1979; 206:1315-1316
60. 1antichymotrypsin in infected and non-infected sputum. Am Rev Respir Dis 1980; 122:81-88
61. Abboud RT, Fera T, Richter A, et al. Acute effect of smoking on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid. Am Rev Respir Dis 1985; 131:1187-1189
62. Abboud RT, Fera T, Richter A, et al. Acute effect of smoking on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid. Am Rev Respir Dis 1985; 131:79-85
63. Cantin AM, Fells GA, Hubbard RC, et al. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 1990; 86:962-971
64. Cooper B, Creeth JM, Donald ASR. Studies of the limited degradation of mucus glycoproteins: the mechanism of the peroxide reaction. Biochem J 1985; 228:615-626
65. Cross CE, Halliwell B, Allen A. Antioxidant protection: a function of tracheobronchial and gastointestinal mucus, Lancet 1984; 1:1328-1330
66. Cantin AM, North SL, Hubbard RC, et al. Normal alveolar epithelial lung fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-157
67. Linden M, Hakansson L, Ohlsson K, et al. Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation 1989; 13:651-658
68. Rahman I, Li XY, Donaldson K, et al. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol Lung Cell Mol Biol 1995; 269:L285-L292
69. Pacht ER, Kaseki H, Mohammed JR, et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers influence on alveolar macrophage cytotoxicity. J Clin Invest 1988; 77:789-796
70. Bui MH, Sauty A, Collet F, et al. Dietary vitamin C intake and concentrations in the body fluids and cells of male smokers and nonsmokers. J Nutr 1992; 122:312-336
71. McGowan SE, Parenti CM, Hoidal JR, et al. Differences in ascorbic acid content and accumulation by alveolar macrophages from cigarette smokers and non-smokers. J Lab Clin Med 1984; 104:127-134
72. McCusker K, Hoidal J. Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters. Am Rev Respir Dis 1990; 141:678-682
73. Kondo T, Tagami S, Yoshioka A, et al. Current smoking of elderly men reduces antioxidants in alveolar macrophages. Am J Respir Crit Care Med 1994; 149:178-182
74. York GK, Pierce TH, Schwartz LS, et al. Stimulation by cigarette smoke of glutathione peroxidase system enzyme activities in rat lung. Arch Environ Health 1976; 31:286-290
75. Toth KM, Berger EM, Buhler CJ, et al. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from non-smokers. Am Rev Respir Dis 1986; 134:281-284
76. 2α-III: an index of oxidant stress. Am J Respir Crit Care Med 1997; 158:1709-1714
77. Dekhuijzen PN, Aben KK, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:813-816
78. Maziak W, Loukides S, Culpitt S, et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:998-1002
79. Culpitt SV, Paredi P, Kharitonov SA, et al. Exhaled carbon monoxide is increased in COPD patients regardless of their smoking habit. Am J Respir Crit Care Med 1998; 157:A787
80. Montuschi P, Corradi M, Ciabattoni G, et al. Breath condensate analysis of 8-isoprostane: a new approach for assessment of oxidative stress in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:A798
81. Noguera A, Busquets X, Sauleda J, et al. Expression of adhesion molecules and g-proteins in circulating neutrophils in COPD. Am J Respir Crit Care Med 1998; 158:1664-1668
82. Duthie GG, Arthur JR, James WPT. Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 1991; 53:10615-10635
83. 2-isoprostanes) in smokers. N Engl J Med 1995; 332:1198-1203
84. Lapenna D, Mezzetti D, Giola SD, et al. Plasma copper and lipid perodixation in cigarette smokers. Free Radic Biol Med 1995; 19:849-85
85. O'Neill CA, Halliwell B, Van der Vliet A, et al. Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J Lab Clin Med 1994; 124:359-370
86. Reznick AZ, Cross CE, Hu ML, et al. Modification of plasma proteins by cigarette smoke as measured by protein carbonyls formation. Biochem J 1992; 286:607-611
87. Cross CE, O'Neill CA, Reznick AZ, et al. Cigarette smoke oxidation of human plasma constituents. Ann NY Acad Sci USA 1993; 686:72-90
88. Petruzzelli S, Hietanen E, Bartsch H, et al. Pulmonary lipid peroxidation in cigarette smokers and lung patients. Chest 1990; 98:930-935
89. Bridges AB, Scott NA, Parry GJ, et al. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med 1993; 2:205-208
90. Duthie GG, Arthur JR, James WPT. Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 1991; 53:1061S-1063S
91. Mazzetti A, Lapenna D, Pierdomenico SD, et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 1995; 112:91-99
92. Antwerpen LV, Theron AJ, Myer MS, et al. Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E and tissue injury. Ann NY Acad Sci USA 1993; 686:53-65
93. Pelletier O. Vitamin C status of cigarette smokers and nonsmokers. Am J Clin Nutr 1970; 23:520-528
94. Chow CK, Thacker R, Bridges RB, et al. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 1986; 5:305-312
95. Bridges RB, Chow CK, Rehm SR. Micronutrients and immune functions in smokers. Ann NY Acad Sci USA 1990; 587:218-231
96. Theron AJ, Richards GA, Rensburg AJ, et al. Investigation of the role of phagocytes and antioxidant nutrients in oxidant stress mediated by cigarette smoke. Int J Vitam Nutr Res 1990; 60:261-266
97. Barton G, Roath OS. Leukocytic ascorbic acid in abnormal leukocyte states. Int J Vitam Nutr Res 1976; 46:271-274
98. Hemilla H, Roberts P, Wikstrom M. Activated polymorphonuclear leukocytes consume vitamin C. FEBS Lett 1984; 178:25-30
99. Van der Vliet A, Smith D, O'Neill CA, et al. Interactions of peroxynitrite and human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 1994; 303:295-301
100. Petruzzelli S, Puntoni R, Mimotti P. Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med 1997; 156:1902-1907
101. Lucey EC, Stone PJ, Breuer R, et al. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters with in vitro observations on elastolysis by these enzymes. Am Rev Respir Dis 1985; 132:362-366
102. Sommerhoff CP, Nadel JA, Basbaum CB, et al. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990; 85:682-289
103. Adler KB, Holden-Stauffer WJ, Repine JE. Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Invest 1990; 85:75-85
104. Chan-Yeung M, Dy Buncio A. Leukocyte count, smoking and lung function. Am J Med 1984; 76:31-37
105. Chan-Yeung M, Abboud R, Dy Buncio A. Peripheral leukocyte count and longitudinal decline in lung function. Thorax 1988; 43:426-468
106. Anderson R, Theron AJ, Richards GA, et al. Passive smoking by human sensitizes circulating neutrophils. Am Rev Respir Dis 1991; 144:570-574
107. Schunemann HJ, Muti P, Freudenheim JL, et al. Oxidative stress and Lung Function. Am J Epiderm 1997; 146:939-948
108. Britton JR, Pavord ID, Richards KA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995; 151:1383-1387
109. Sridhar MK, Galloway A, Lean MEJ, et al. An out-patient nutritional supplementation programme in COPD patients. Eur Respir J 1994; 7:720-724
110. Steinberg FM, Chait A. Antioxidant vitamin supplementation and lipid peroxidation in smokers Am J Clin Nutr 1998; 68:319-327
111. Keating SVM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumour necrosis factor-induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
112. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998; 53:601-612
113. Watchorn T, Mulier B, MacNee W. Does increasing intracellular glutathione inhibit cytokine-induced nitric oxide release and Nf-κB activation. Am J Respir Crit Care Med 1998; 157:A889
114. Parmentier M, Drost E, Hirani N, et al. Thiol antioxidants inhibit neutrophil chemotaxis by decreasing release of IL-8 from macrophages and pulmonary epithelial cells. Am J Respir Crit Care Med 1999; 159:A286
115. Cross CE, Van der Vliet A, O'Neill CA, et al. Oxidants antioxidants and respiratory tract lining fluids. Environ Health Perspect 1994; 102(Suppl 10):185-191
116. Rahman I, Lawson MF, Smith CAD, et al. Induction of γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996; 396:21-25
117. Rahman I, Bel A, Mulier B, et al. Transcriptional regulation of γ-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem Biophys Res Commun 1996; 229:832-837
118. Rahman I, MacNee W. Characterization of γ-glutamylcysteine-heavy subunit gene promoter: critical role for AP-1. FEBS Lett 1998; 427:129-133
119. Rahman I, Antonicelli F, MacNee W. Molecular mechanisms of the regulation of glutathione synthesis by tumour necrosis factor-α and dexamethasone in human alveloar epithelia cells. J Biol Chem 1999; 274:5088-5096
120. Gilks CB, Price K, Wright JL, et al. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 1998; 152:269-278
121. Muller T, Gebel S. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis 1998; 19:797-801
122. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80:501-522
123. Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1380-1391
124. Huang S-L, Su C-H, Chang S-C. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156:1436-1439
125. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350:630-633
126. Clausen J. The influence of antioxidants on the enhanced respiratory burst reaction in smokers. Ann N Y Acad Sci USA 1991; 629:337-341
127. Davis WB, Pacht ER, Spatafora M, et al. Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers. J Lab Clin Med 1998; 111:293-298
128. Hoshino E, Shariff R, Van Gossum A, et al. Vitamin E suppresses increased lipid peroxidation in cigarette smokers. J Parenter Enter Nutr 1990; 40:300-305
129. Pacht ER, Kaseki H, Mohammed JR, et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers Influence on alveolar macrophage cytotoxicity. J Clin Invest 1988; 77:789-796
130. MacNee W, Bridgeman MME, Marsden M, et al. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells. Am J Med 1991; 90:60s-66s
131. Ross D, Norbeck K Moldeus P. The generation and subsequent fate of gluthionyl radicals in biological systems. J Biol Chem 1985; 260:15028-15032
132. Marrades RM, Roca J, Barbera J, et al. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med 1997; 156:425-430
133. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983; 52:711-760
134. Karlsen RL, Grofova I, Malthe-Soren D, et al. Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci USA 1993; 686:72-90
135. Bridgeman MME, Marsden M, MacNee W, et al. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 1991; 46:39-42
136. Bridgemen MME, Marsden M, Selby C. Effect of N-acetyl. cysteine on the concentrations of thiols in plasma bronchoalveolar lavage fluid and lining tissue. Thorax 1994; 49:670-675
137. Bowman G, Backer U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis. Eur J Respir Dis 1983; 64:405-415
138. Rasmusse JB, Glennow C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur J Respir Dis 1988; 1:351-355
139. British Thoracic Society Research Committee. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 1985; 40:823-835
140. Gillissen A, Jaworska M, Orth M, et al. Nacystelyn: a novel lysine salt of N-acetylcysteine to augment cellular antioxidant defense in vitro. Respir Med 1997; 91:159-168
141. Nagy AM, Vanderbist F, Parij N, et al. Effect of the mucoactive drug Nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm Pharmacol Ther 1997; 10:287-292
142. Anderson ME, Powrie F, Puri R, et al. Glutathione monoethyl ester: preparation uptake by tissues and conversion to glutathione. Arch Biochem Biophys 1985; 239:538-548
143. Tsan M, White JE, Rosano CL. Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester. J Appl Physiol 1989; 66:1029-1034
144. Tsan MF, Phillips PG. L-2-oxothiazolidine-4-carboxylate protects cultured endothelial cells against hyperoxia-induced injury. Inflammation 12:113-121